Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.

@article{Marcovina2003ReportOT,
  title={Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.},
  author={Santica M. Marcovina and Marlys L Koschinsky and John J. Albers and Sonia Skarlatos},
  journal={Clinical chemistry},
  year={2003},
  volume={49 11},
  pages={1785-96}
}
It has been estimated that approximately 37% of the US population judged to be at high risk for developing coronary artery disease (CAD), based on the National Cholesterol Education Program guidelines, have increased plasma lipoprotein(a) [Lp(a)], whereas Lp(a) is increased in only 14% of those judged to be at low risk. Therefore, the importance of establishing a better understanding of the relative contribution of Lp(a) to the risk burden for CAD and other forms of vascular disease, as well as… CONTINUE READING
82 Citations
89 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 82 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 89 references

Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the Clinical Chemistry

  • VW Armstrong, J Schleef, J Thiery, R Muche, P Schuff-Werner, T Eisenhauer
  • Eur J Clin Invest
  • 2003
1 Excerpt

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) Clinical Chemistry

  • G Utermann, HJ Menzel, HG Kraft, HC Duba, HG Kemmler, C. Seitz
  • J Clin Invest
  • 2003

Similar Papers

Loading similar papers…